Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cardiex.
RELATED STOCKHEAD STORIES
Health & Biotech
Cardiex cardiovascular health innovation wins major US award
Health & Biotech
Cardiex Soars 15pc as MedTech eyes record revenue
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Cardiex jumps 15pc on sales update; Recce’s drug included in WHO’s report
Health & Biotech
Cardiex’s CONNEQT Pulse included on the US Blood Pressure Validated Device List
Health & Biotech
ASX Health Stocks: Recce, Cynata say their diabetic foot ulcer trials are going great guns
News
Top 10 at 11: Enova inks rare earth Brazil deal, Credit Clear upgrades FY24 guidance
Health & Biotech
Regal cornerstones $14m CardieX raise as medtech prepares to debut world-first vascular biometric monitor
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Range-bound benchmark ends washboard flat, cheapened us all during August
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Health & Biotech
Strokes cost the Australian economy billions, but these biotech players could change that
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
MST upgrades CardieX to 5x current share price as FDA green lights world-first vascular biometric monitor
News
